cabozantinib,atezolizumab
exelixis,medsir,roche
['urothelial carcinoma', 'atezolizumab', 'cosmic021', 'cabozantinib', 'urothelial', 'medsir']
fantastic presentation by from of #cosmic021 study showing clinical activity &amp; manageable toxicity of cabozantinib + atezolizumab in urothelial carcinoma - 1l systemic for cisplatin-based chemo eligible or ineligible pts; 2l or later for prior ici
#asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc